| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965351 | Vaccine | 2014 | 8 Pages |
Abstract
QIV provided superior immunogenicity for the added B strain without affecting the antibody response to the TIV strains, and without compromising safety.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Juan Carlos Tinoco, Noris Pavia-Ruz, Aurelio Cruz-Valdez, Carlos Aranza Doniz, Vijayalakshmi Chandrasekaran, Walthère Dewé, Aixue Liu, Bruce L. Innis, Varsha K. Jain,